Back to catalogue
№ 326 30 filings · 2021-09-06 → 2026-09-16

PCI-PAL PLC

PCIP
Technology Share price 76.00p Market cap £55m Overall fit 505 /1000

Genuine SaaS operating leverage and reasonable valuation (2.0x ARR) with real but indirect AI-agent tailwind; downside protection weakened by audit overhang and small cash cushion keeps this out of the top band.

Fair value range 82p–123p Mid case · £74m
Absolute upside +35.2% vs current market cap
Conviction 3/5 confidence in undervalued call
Supports the call
  • Clean ARR/CARR/GRR/NRR disclosure supports EV/ARR anchoring
  • Multiple valuation approaches converge on 82-123p range
  • Consistent partner-first strategy with observable channel traction
Limits the call
  • Live FY26 audit delay on revenue recognition matters
  • History of prior-period restatement (FY24) reduces confidence in reported metrics
Methodology

EV/ARR multiple cross-checked with EV/Revenue

In one line · bull case

Debt-free cloud SaaS with 90% gross margin, 96% GRR and 27% ARR growth priced at just 2.0x ARR, offering re-rating potential as AI-agent transaction volumes ramp through its partner ecosystem.

In one line · biggest risk

The Sep 2026 audit delay on revenue recognition follows a FY24 restatement and could force a meaningful re-cut of reported financials, undermining the ARR-multiple valuation.

Drivers
AI beneficiary 48 /100
Real AI-agent payment integration angle (MCP, PolyAI, Cognigy, CCaaS-native bots) but volumes still small; not the dominant driver.
Operating leverage 74 /100
True SaaS: 90% gross margin, fixed AWS/R&D/central cost base; FY25 showed 7x EBITDA leverage on 25% revenue growth before deliberate FY26 re-investment.
Earnings vs expectations 52 /100
Mixed: beat FY26 trading update consensus, but FY24 revenue deferral and current FY26 audit delay temper the record.
Growth momentum 62 /100
ARR compounding 20-27% organically; reported revenue growth 9% (14% comparable) reflects deployment lag rather than demand weakness.
Moat 55 /100
Meaningful partner-ecosystem lock-in (70%+ CCaaS coverage), reciprocal integrations, and granted patents on cloud voice integration; not a durable multi-decade moat.
Earnings quality 42 /100
High recurring-revenue mix is a positive, but repeated revenue-recognition rework (FY24 restatement, FY26 audit delay) is a real quality flag.
Management quality 55 /100
Consistent multi-year execution against stated ARR growth and partner strategy, offset by two revenue-recognition incidents on their watch.
Cyclicality 25 /100
Defensive SaaS subscription model with 95%+ GRR and mission-critical compliance service.
Leverage 15 /100
Debt-free with £4m cash and £3m undrawn RCF; balance sheet in net-liability territory purely due to deferred income accounting.
Value-trap signals · 3
  • FY26 audit delay explicitly citing revenue recognition matters (Sept 2026)
  • Prior-period revenue restatement in FY24 accounts (H1 FY24 restated in March 2025 interims)
  • Net liability balance sheet position (accounting artifact but limits flexibility)

PCI-PAL PLC (PCIP.L) — Investment Research Note

Executive summary

PCI-Pal is a UK-listed, cloud-native SaaS provider of PCI-compliant secure payment solutions for contact centres, sold predominantly via a partner ecosystem of the world's leading CCaaS/UCaaS vendors (Genesys, NICE, Zoom, RingCentral, Talkdesk, 8x8, Amazon Connect). Across the period covered, the group has scaled ARR from £11m (FY22) to c.£24.8m (FY26), maintained top-quartile GRR (95-97%), delivered 88-90% gross margins, and turned adjusted EBITDA profitable in FY25 before deliberately re-investing in FY26. The single most important item for valuation today is the 16 September 2026 announcement that FY26 audit is delayed "to finalise the assessment of certain revenue recognition and related matters" — a live risk that overhangs an otherwise attractive recurring-revenue growth story.

Fair value estimate

Methodology: EV/ARR multiple (the natural anchor for a debt-light SaaS company with 90%+ recurring, 96% GRR, 105% NRR and 21-27% ARR growth). ARR at ~£24.8m expected FY26 exit 2026-09-16 update; 2026-07-28 trading update.

Assumed multiples reflect a small-cap AIM discount, modest revenue growth (9% headline, 14% comparable), the audit overhang, and low-single-digit EBITDA margins in the current investment cycle:

  • Low case: 2.4x ARR → EV c.£59m → c.82p/share
  • Mid case: 3.0x ARR → EV c.£74m → c.102p/share
  • High case: 3.6x ARR → EV c.£89m → c.123p/share

Fair value range: 82p – 123p (mcap range: £59m – £89m). Current market cap £50.0m implies just 2.0x ARR — cheap versus scaled SaaS comparables (3-5x). Upside to mid-point: c.43%.

Sector context

Sector classification (Technology / Software) is confirmed and appropriate. On a quality basis, PCI-Pal ranks above typical AIM tech peers — 90% gross margin, >90% recurring, 95%+ GRR, debt-free, and a genuine channel moat. Growth (mid-to-high teens organic revenue, 20%+ ARR) is above sector median. Balance sheet leverage is below peers (net cash £4m). Closest listed comparables: Eckoh (until de-listing, the most direct UK peer), Cerillion, NICE Ltd (US, much larger), and Five9 as an ecosystem adjacency.

Investment thesis

  1. Structural pull-through from CCaaS/AI adoption at contact centres — PCI-Pal sits as the compliance/payment layer inside 70%+ of CCaaS market and is integrating MCP support so AI agents can invoke its payment orchestration natively 2026-03-03 interims. As voice and chat bots increasingly transact, PCI-Pal is a plausible incremental beneficiary — signed its "largest conversational AI-related secure payment contract" in Q1 FY26.
  2. True SaaS operating model with visible operating leverage — 90% gross margin, 91% recurring revenue mix, 96% GRR, 105% NRR, and CARR of £27.9m vs FY26 revenue of £24.6m provides high forward visibility 2026-09-16; 2025-09-09 FY25 results.
  3. Reasonable valuation on ARR basis — 2.0x ARR is below scaled SaaS peers; even at unchanged FY26 EBITDA of £1.1m, the market is pricing minimal terminal value for a 27% ARR grower with 96% GRR 2026-07-28 trading update.

Key risks

  1. Revenue recognition / audit delay (Sept 2026) — FY26 results delayed pending resolution of "certain revenue recognition and related matters." Sets precedent — the FY24 accounts already contained a £0.7m revenue deferral and a prior-period restatement 2026-09-16; 2024-08-28 trading update; 2025-03-04 interims Note 7 restatement.
  2. Small absolute scale, thin cash cushion — £4.0m closing cash, £3.0m undrawn HSBC RCF, and net liabilities of £1.98m at H1 FY26 (deferred income-driven but still a fragile balance sheet if audit issues escalate) 2026-03-03 interims.
  3. Growth optics vs. bull-case pricing — reported revenue growth was 9% in FY26 (14% comparable). If ARR-to-revenue conversion continues to lag, the multiple may re-rate slowly even if the fundamentals are sound 2026-07-28 trading update.

Operating leverage

PCI-Pal has genuine, structural operating leverage. Gross margin is c.90% and the largest cost lines are fixed: R&D headcount (capitalised at £0.9m/H1 into intangibles), the AWS platform (£1.05m annual, ~5% of revenue and largely fixed to scale), and central overhead 2025-09-09 FY25 review; 2026-03-03 interims. In FY25 revenue grew 25% and adjusted EBITDA grew 167% (£0.87m→£2.32m) — a ~7x incremental margin drop-through. Management chose to reinvest in FY26 (Adjusted EBITDA guided to £1.1m on 9% revenue growth), so the leverage is currently masked. On a normalised basis, a 15-20% revenue upside from AI-agent volumes or partner ramp (e.g. Zoom, RingCentral) should convert to 40-60%+ incremental gross profit. The observable inflection point is the platform's fixed-cost base against a growing ARR line: at £25m ARR the model is nearly at breakeven; at £35m ARR and same cost base, adjusted EBITDA plausibly steps to £6-9m.

Value-trap signals

  • Audit delay for revenue recognition (Sept 2026) — non-trivial, live signal.
  • Prior-year revenue restatement — FY24 accounts required a prior-period adjustment and £0.7m revenue deferral into FY25; H1 FY24 was restated in the March 2025 interims 2024-08-28; 2025-03-04 Note 7.
  • Net liability balance sheet — accounting artifact of deferred income treatment, but reduces flexibility.
  • Not identified: no dividend cuts (never paid), no repeated guidance misses (FY26 beat consensus in July update), no customer concentration issues (largest customer 17% of revenue), no obvious related-party issues, no terminal-decline industry.

Earnings vs. expectations

  • FY24 (Oct 2024 results): Missed the initially-guided full-year profit; adjusted PBT £(0.57)m vs prior guidance for full-year profit — driven by the £0.7m revenue deferral flagged 28-Aug-2024. Miss.
  • H1 FY25 (Mar 2025): Delivered as guided in the January trading update — record H1 ACV, ARR up 21%. Met.
  • FY25 (Sep 2025): Revenue £22.48m, Adj PBT £0.81m — "in line with market expectations". Met.
  • H1 FY26 (Mar 2026): Adjusted EBITDA £0.20m vs prior year £0.95m — as guided reflecting deliberate investment. Met.
  • FY26 trading update (Jul 2026): Revenue £24.6m vs consensus £23.7m, Adj EBITDA £1.1m vs consensus £0.85m. Beat.
  • FY26 results delay (Sep 2026): Audit still open on revenue recognition. Neutral / negative signal pending.

Pattern: broadly meets guidance with occasional revenue-recognition-driven misses; management is candid but the accounting has repeatedly required rework.

Conviction

Conviction: 3 (moderate). Anchors: (i) clear, well-disclosed ARR/CARR/GRR/NRR metrics that make an ARR-multiple valuation defensible; (ii) consistent partner-ecosystem strategy with observable traction; (iii) multiple valuation approaches (EV/ARR, EV/Revenue) converge on a similar range. Limiters: (i) the live FY26 audit delay on revenue recognition — until resolved, any point estimate could move meaningfully; (ii) FY24 restatement history shows this isn't a one-off.

Filings consulted · 40

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-09-16Update ON Timing OF Full Year Results Announcement2026-09-16_9773925_update-on-timing-of-full-year-results-announcement.md1.00
  2. 2026-07-28Trading Update2026-07-28_9689852_trading-update.md0.85
  3. 2026-03-03Interim Results Analyst Briefing Amp Investor Pres2026-03-03_9454652_interim-results-analyst-briefing-amp-investor-pres.md0.77
  4. 2026-02-03Trading Update2026-02-03_9403389_trading-update.md0.72
  5. 2025-12-01Result OF Agm2025-12-01_9268182_result-of-agm.md0.26
  6. 2025-11-11Capital Markets Day2025-11-11_9225025_capital-markets-day.md0.81
  7. 2025-11-06Annual Financial Report Amp Notice OF Agm2025-11-06_9217763_annual-financial-report-amp-notice-of-agm.md0.26
  8. 2025-09-09Final Results Analyst Briefing Amp Investor Pres2025-09-09_9095024_final-results-analyst-briefing-amp-investor-pres.md0.65
  9. 2025-03-04Interim Results Analyst Briefing Amp Investor Pres2025-03-04_8761362_interim-results-analyst-briefing-amp-investor-pres.md0.58
  10. 2025-01-27Trading Update2025-01-27_8706026_trading-update.md0.55
  11. 2024-12-11Result OF Agm2024-12-11_8605044_result-of-agm.md0.20
  12. 2024-12-11Agm Statement2024-12-11_8603001_agm-statement.md0.26
  13. 2024-11-14Annual Financial Report Amp Notice OF Agm2024-11-14_8551043_annual-financial-report-amp-notice-of-agm.md0.20
  14. 2024-10-22Final Results Analyst Briefing Amp Investor Pres2024-10-22_8500000_final-results-analyst-briefing-amp-investor-pres.md0.65
  15. 2024-08-28Trading Update New Partner Amp Notice OF Results2024-08-28_8386604_trading-update-new-partner-amp-notice-of-results.md0.38
  16. 2024-03-12Result OF Oversubscribed Placing Amp Tvr2024-03-12_8083890_result-of-oversubscribed-placing-amp-tvr.md0.32
  17. 2024-03-12Proposed Placing TO Raise UP TO 3 5M2024-03-12_8082228_proposed-placing-to-raise-up-to-3-5m.md0.32
  18. 2024-02-27Interim Results Board Change Amp Presentations2024-02-27_8057180_interim-results-board-change-amp-presentations.md0.41
  19. 2024-02-20Notice OF Results Analyst Amp Investor Presentation2024-02-20_8045511_notice-of-results-analyst-amp-investor-presentation.md0.32
  20. 2024-02-06Trading Update Amp Notice OF Results2024-02-06_8023000_trading-update-amp-notice-of-results.md0.38
  21. 2023-12-12Result OF Agm2023-12-12_7937529_result-of-agm.md0.14
  22. 2023-12-12Agm Statement2023-12-12_7935752_agm-statement.md0.18
  23. 2023-11-24Annual Financial Report Amp Notice OF Agm2023-11-24_7901729_annual-financial-report-amp-notice-of-agm.md0.14
  24. 2023-11-09Final Results Analyst Briefing Amp Investor Pres2023-11-09_7869773_final-results-analyst-briefing-amp-investor-pres.md0.45
  25. 2023-10-03Detail ON Patent Case Outcome Amp Trading Update2023-10-03_7792333_detail-on-patent-case-outcome-amp-trading-update.md0.38
  26. 2023-08-09Trading Update2023-08-09_7684442_trading-update.md0.21
  27. 2023-03-14Interim Results Analyst Briefing Amp Investor Pres2023-03-14_7432822_interim-results-analyst-briefing-amp-investor-pres.md0.23
  28. 2023-02-02Trading Update Amp Notice OF Results2023-02-02_7352656_trading-update-amp-notice-of-results.md0.21
  29. 2022-10-27Result OF Agm2022-10-27_7203900_result-of-agm.md0.07
  30. 2022-10-27Agm Statement2022-10-27_7160770_agm-statement.md0.10
  31. 2022-10-04Annual Financial Report Amp Notice OF Agm2022-10-04_7200846_annual-financial-report-amp-notice-of-agm.md0.07
  32. 2022-09-06Final Results Analyst Briefing Amp Investor Pres2022-09-06_7211595_final-results-analyst-briefing-amp-investor-pres.md0.25
  33. 2022-07-27Trading Update Amp Notice OF Results2022-07-27_7179726_trading-update-amp-notice-of-results.md0.21
  34. 2022-04-26Trading Update2022-04-26_7041632_trading-update.md0.21
  35. 2022-03-01Interim Results Analyst Briefing Amp Investor Pres2022-03-01_6962176_interim-results-analyst-briefing-amp-investor-pres.md0.23
  36. 2022-01-19Trading Update Notice OF Results Amp Investor Pres2022-01-19_6907800_trading-update-notice-of-results-amp-investor-pres.md0.21
  37. 2021-11-10Result OF Agm2021-11-10_6692136_result-of-agm.md0.07
  38. 2021-11-10Agm Trading Update2021-11-10_6690792_agm-trading-update.md0.21
  39. 2021-10-14Annual Financial Report Amp Notice OF Agm2021-10-14_6811338_annual-financial-report-amp-notice-of-agm.md0.07
  40. 2021-09-06Final Results Amp Investor Presentation2021-09-06_6719787_final-results-amp-investor-presentation.md0.10

This research note was authored by a large language model after reading 30 regulatory filings published between 2021-09-06 and 2026-09-16. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.